 Jaguar CEO Lisa Conte Will Also Participate in an Orphan Drug Panel Presentation on September 28th During the Lytham Partners Fall 2022 Investor Conference SAN FRANCISCO, CA ACCESSWIRE September 22, 2022 Jaguar Health, Inc. NASDAQ:JAGX Jaguar or the Company today announced that on September 28, 2022 Lisa Conte, Jaguars president, founder, and CEO, will present at the virtual Lytham Partners Fall 2022 Investor Conference in addition to participating in a panel presentation titled Orphan Drugs: Innovative Companies Addressing Rare Diseases at the conference. Additionally, Conte will present at the Ladenburg Thalmann 2022 Healthcare Conference on September 29, 2022. 